The sale is small and routine for a director; no material impact expected. Monitor for any larger insider sales or changes in insider filing patterns ahead of the next earnings report.
CORT drugs
CORT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $74.53entry
- T+1 · 5d ago −1.10%α −0.75% · $73.71
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Director Daniel Swisher Jr. filed a Form 144 notice of intent to sell 1,500 shares of Corcept Therapeutics common stock, with an estimated aggregate market value of $112,537.50. The shares were acquired through exercise of stock options on the same day. This is a small, routine sale by a director and represents a negligible fraction of the company's $8.0B market cap.
Key Facts
- Insider: Daniel Swisher Jr., Director
- Shares to be sold: 1,500 shares of common stock
- Estimated value: $112,537.50
- Acquisition: shares acquired via exercise of stock options on 2026-11-10
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Proposed sale date: 2026-11-10
- Market cap of CORT: $8.0B
Financial Impact
Sale of 1,500 shares valued at ~$112.5K, representing less than 0.002% of market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- No additional context on the insider's total holdings is provided
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010947 |
| Document: 0001950047-26-010947-index.html | 0001950047-26-010947 |
| Document: 0001950047-26-010947.txt | 0001950047-26-010947 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20266d ago 144 Neutral 2/10 Viewing Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers